Journals / Türk Göğüs Kalp Damar Cerrahisi Dergisi / 1999 / Cilt: 7 - Sayı: 2

Our results on the rheumatic mitral valve reoperations

Romatizmal mitral kapak cerrahisinde reoperasyon sonuçlarımız

Pages
106–111
Publication Date
2022-09-02
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Blood conservation, total myocardial protection, good timing and a good preoperative effort capacity are the factors which may reduce mortality and morbidity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:We present the details and early period results of the patients, with reoperated rheumatic mitral valve disease.
📊
Key Findings & Data:Between January, 1993 and January, 1998, 59 patiens, had a second operation for rheumatic mitral disease.
💡
Conclusion & Impact:Blood conservation, total myocardial protection, good timing and a good preoperative effort capacity are the factors which may reduce mortality and morbidity.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

We present the details and early period results of the patients, with reoperated rheumatic mitral valve disease. Between January, 1993 and January, 1998, 59 patiens, had a second operation for rheumatic mitral disease. The average interval between their first and second operations was 10.8±2.9 years. At their first operation, closed mitral valvotomy in 35 patients (59.3), open mitral valvotomy in 17(28.9), allcarbon tilting disc prosthesis valve implantation in mitral position in 5(8.5%) and bioprosthesis valve implantation in mitral position in 2 (3.3%) had been done. All patiens were administered 560 mg of aprotinin to reduce blood transfusion besides autotransfusion during the operations. We expressly shortened the short aortic crossclamp duration. Within the postoperative 24 hours, while the average drainage volume was 252.4±66.1 ml, the average erytrocite suspansion volume to be tranfused indicated 1.2±0.6 units. No mortality was registered during either early or late stages in patiens with class II, III preoperative functional capacity and also in patients with acute bacterial endocarditis indication, whereas two patients (3.3%), in functional class IV, died postoperatively within the early period. Blood conservation, total myocardial protection, good timing and a good preoperative effort capacity are the factors which may reduce mortality and morbidity.

Özet

Kliniğimizde romatizmal mitral kapak hastalığı nedeni ile ikinci kez ameliyat edilen hastalar ile ilgili detay sunulacak ve erken dönem sonuçları bildirilecektir. Ocak 1993 ve Ocak 1998 tarihleri arasında, daha önce romatizmal mitral kapak hastalığı nedeni ile ameliyat edilmiş olan 59 hasta ikinci kez ameliyat edildi. İlk ameliyat ile ikincisi arasındaki süre ortalama 10.8±2.9 yıldır. İlk ameliyatta bu hastaların 35'ine (%59.3) kapalı mitral valvotomi, 17'ine (28.9) açık mitral valvotomi, 5 hastaya (%8.5) all carbon tilting disk protez kapak, 2 hastaya (%3.3) biyoprotez kapak implantasyonu yapılmıştı. Hastalara ameliyat sırasında kan transfüzyonunu azaltmaya yönelik olarak 560 mg aprotinin verildi ve ototransfüzyon uygulandı. Aort kros klemp süresinin kısa olmasına özen gösterildi. İlk 24 saatte ortalama drenaj miktarı 252.4±66.1 ml ve tranfüze edilen eritrosit süspansisyonu miktarı ortalama 1.2 ± 0.6 ünite oldu. Preoperatif fonksiyonel kapasitesi klas II ve III olan hastalar ve akut bakteriyel endokardit nedeni ile ikinci kez ameliyat edilenlerde, erken ve geç dönemde mortalite olmadı. Buna karşılık fonksiyonel kapasitesi klas IV olan iki hasta (%3.3) postoperatif erken dönemde kaybedildi. Kan korumaya yönelik önlemler, total myokardiyal koruma, peroperatif efor kapasitesini iyi olması, iyi bir cerrahi zamanlama reoperatif kapak cerrahisinin mortalite ve morbiditesini azaltır.

🔖

Cite This Article

TÜRKAY, C., METE, A., AK, İ., BAYEZİD, Ö., GÖLBAŞI, İ., ÇELİK, B. (2022). Our results on the rheumatic mitral valve reoperations. Türk Göğüs Kalp Damar Cerrahisi Dergisi, Cilt: 7 - Sayı: 2, 106–111. https://ajindex.com/articles/425661

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Duran CG. Reoperations on the mitral and tricuspid valves. Stark J, Pacifico A.D; Reoperations in Cardiac Surgery, Springer-Verlag 1989
  2. Cohn LH, Aranki SF, Rizzo RJ, et al. Decrease in operative risk of reoperative valve surgery. Ann Thorac Surg 1993; 56: 15-21
  3. Lytle BW, Cosgrove DM, Taylor PC, et al. Reoperations for valve surgery: perioperative mortality and determinants of risk for 1.000 patients, 1958-1984. Ann Thorac Surg 1986; 42: 632-643
  4. Bidstrup BP, Royston D, Sapsford RN, Taylor KM. Reduction in blood loss use after cardiopulmonary bypass with high dose aprotinin (Trasylol). J Thorac Cardiovasc Surg 1989; 97: 364-72
  5. Jamieson WR, Dryden PJ, O′ Connor JP, Sadeghi H, ansley DM, Merrick PM. Beneficial effect of both tranexamic acid and aprotinin on blood loss reduction in reoperative valve replacement surgery. Circulation 1997; 96(9 Suppl): II-II96100
  6. Gundry SR, Razzouk AJ, Vigesaa RE, Vang N, Bailey LL. Optimal delivery of cardioplegic solution for redo operations. J Thorac Cardiovasc Surg 1992; 103: 896-901
  7. Braxton JH, Higgins RS, Schwann TA, et al. Reoperative mitral valve surgery via right thoracotomy: decrease blood loss and improved hemodynamics. J Heart Valve Dis 1996; 5(2): 169-73
  8. Antunes MJ, Magalhaes MP. Isolated replacement of a prosthesis or a bioprothesis in the mitral valve position. Am J Cardiol 1987; 59: 346-9
  9. Stewart S, DeWeese JA. The determinants of survival following reoperation on prosthetic cardiac valves. Ann Thorac Surg 1978; 25: 555
  10. Miller DC, Oyer PE, Stinson EB, et al. Ten to fifteen year reassessment of the perfomance characteristics of the Starr-Edwards Model 6120 mitral valve prosthesis. J Thorac Cardiovasc Surg 1983: 85; 1
  11. Ivert TSA, Dismukes WE, Cobbs CG, et al. Prosthetic valve endocarditis. Circulation 1984; 69: 223
  12. Jung JY, Saab SB, Almond CH. The case for early surgical treatment of left-sided primary infective endocarditis: A collective review. J Thorac Cardiovasc Surg 1975; 70: 509-518
  13. Wilcox BR. The role of surgery in the management of infective endocarditis. Roberts AJ; Difficult problems in cardiac surgery, Year Book Medical Publishers, Inc. Chica, 1985
  14. Larbalestier RI, Kinchla NM, Aranki SF, Couper GS, Collins JJ Jr, Cohn LH. Acute bacteriel endokarditis: Optimizing surgical results. Circulation 1992; 86 (suppl 2): 68-74
  15. Cohn LH, Koster JK, Vandevanter S, Collins JJ Jr. The in-hospital risk of re-replacement of disfunctional mitral and aortic val